Skip to Main Content

Paper Details

Ascorbic acid-induced TET activation mitigates adverse hydroxymethylcytosine loss in renal cell carcinoma.
J Clin Invest
51
2019
5-hydroxymethylcytosine, 5hmC, Ascorbic acid, L2HG, L2HG dehydrogenase, L2HGDH, TET, ccRCC, clear cell renal cell carcinoma, cytosine, recombinant TET-2 protein, renal cell carcinoma, ten eleven translocation (TET) enzymes, tumor
Author NameAffiliation
Lance C PagliaroMayo Clinic
Masako SuzukiAlbert Einstein College of Medicine, Montefiore Medical Center
John M GreallyAlbert Einstein College of Medicine, Montefiore Medical Center
Katalin SusztakUniversity of Pennsylvania Perelman School of Medicine
  • 1 - 4

Datasets

Release 1.2